Inadequacy of clinical trial designs and data to control for the confounding impact of race/ethnicity in response to treatment in multiple sclerosis

JAMA Neurol. 2014 Aug;71(8):943-4. doi: 10.1001/jamaneurol.2014.79.
No abstract available

MeSH terms

  • Black or African American*
  • Clinical Trials as Topic / standards*
  • Humans
  • Multiple Sclerosis / drug therapy*
  • Patient Selection*
  • Treatment Outcome*